CME Programme
-
Regular Activities
Real-world Insights: Sacituzumab Govitecan in HER2- mBCDate: 23/04/2024 Enquiries: Hong Kong Breast Oncology Group CME Points Awarded: 2 points
CME Programme
Date: | 23/04/2024 |
Enquiries: | Hong Kong Breast Oncology Group |
CME Points Awarded: | 2 points |